Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases

Novartis Pharmaceuticals · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
lung-cancernon-small-cell-lung-cancernsclc
non-small cell lung carcinoma (nsclc), non-small cell lung carcinoma, non-small cell lung cancer, nsclc, treatment of lung cancer after first metastasi, lung cancer, lung adenocarcinoma, squamous cell lung carcinoma, large-cell lung carcinoma, large-cell lung cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834778
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.